Medical Device Contract Manufacturing Market to Reach USD 249.27 Billion by 2035 at 9.2% CAGR
Medical Device Contract Manufacturing Market Overview
The Medical Device Contract Manufacturing Market is expanding as medical device manufacturers increasingly outsource design, production, quality management, packaging, sterilization, and regulatory activities to specialized contract manufacturing partners. Rising cost pressures, increasingly complex regulatory requirements, demand for connected and combination devices, aging populations, supply-chain resilience initiatives, and adoption of smart-factory technologies are supporting market growth.
According to the Market Research Future report updated August 24, 2026, the global Medical Device Contract Manufacturing Market was valued at USD 102.48 Billion in 2025 and is projected to grow from USD 112.87 Billion in 2026 to USD 249.27 Billion by 2035, registering a CAGR of 9.2% during 2026–2035. North America led the market with 41.5% share in 2025, while Asia-Pacific is the fastest-growing region with a projected CAGR of 11.1%. In-vitro Diagnostic Devices captured 29.8% share, Device Development and Manufacturing Services accounted for 57.0% of service revenue, and Quality Management Services are projected to grow at 12.8% CAGR through 2035.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.marketresearchfuture.com/sample_request/11204
Key players driving innovation and competitiveness in the Medical Device Contract Manufacturing Market include:
Jabil Inc.
Flex Ltd.
Integer Holdings Corporation
Celestica Inc.
Plexus Corp.
Phillips-Medisize
Gerresheimer AG
West Pharmaceutical Services
Nordson MEDICAL
Tecomet Inc.
The market is being shaped by OEM cost optimization, increasing regulatory complexity, growing demand for connected and combination products, Industry 4.0 adoption, near-shoring strategies, and government incentives for domestic medical-device manufacturing. In-vitro diagnostic devices remain the largest device-type segment, while drug-delivery devices are gaining momentum as biologics and biosimilars increasingly require sophisticated delivery systems. Device Development and Manufacturing Services remain the dominant service category because OEMs increasingly seek end-to-end manufacturing partnerships.
The Medical Device Contract Manufacturing Market can be segmented by Device Type into IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Orthopedic Devices, Respiratory Care Devices, Ophthalmology Devices, Surgical Devices, Diabetes Care Devices, Dental Devices, Endoscopy and Laparoscopy Devices, Gynecology and Urology Devices, Personal Care Devices, Neurology Devices, Patient Monitoring Devices, Patient Assistive Devices, and Other Devices. By Class, it includes Class I Medical Device, Class II Medical Device, and Class III Medical Device. By Service, it covers Device Development and Manufacturing Services, Quality Management Services, Packaging and Assembly Services, and Others. By Region, the market includes North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
The growing need for specialized and cost-efficient medical-device production is creating opportunities for contract manufacturers, medical-device OEMs, pharmaceutical companies, diagnostic companies, biotechnology firms, and healthcare technology providers. Additive manufacturing, smart factories, digital twins, combination drug-device products, vertically integrated manufacturing, advanced sterilization, and data-driven manufacturing services can support market differentiation and expansion.
Recent Developments and Market Trends:
Smart-factory technologies including digital twins, real-time statistical process control, and automated inspection are improving manufacturing efficiency and quality control.
Drug-delivery devices are gaining adoption as biologics, biosimilars, autoinjectors, wearable infusion systems, and combination products expand.
Quality management services are growing as medical-device companies increasingly outsource regulatory submissions, post-market surveillance, inspection, testing, and compliance activities.
Additive manufacturing and 3D printing are creating opportunities for patient-specific devices and complex anatomical products.
Near-shoring and government manufacturing incentives are encouraging new production capacity in North America and Asia-Pacific, particularly in India.
Reasons to Buy the Report:
Provides comprehensive insights into the Medical Device Contract Manufacturing Market dynamics, trends, opportunities, and growth potential.
Helps identify opportunities across IVD, cardiovascular, orthopedic, drug-delivery, surgical, diagnostic imaging, and other medical-device categories.
Offers detailed segmentation analysis across device type, class, service, and geographic markets.
Includes competitive intelligence covering leading contract manufacturers, medical-device production specialists, and integrated manufacturing providers.
Supports informed decisions using market forecasts, OEM outsourcing trends, regulatory requirements, smart-factory adoption, combination-product growth, supply-chain strategies, and regional opportunities.
Future Outlook:
The future of the Medical Device Contract Manufacturing Market will be shaped by continued OEM outsourcing, regulatory complexity, connected-device proliferation, smart-factory adoption, supply-chain localization, and increasing demand for specialized manufacturing capabilities. In-vitro Diagnostic Devices should remain the largest device-type segment with a 29.8% share, while Drug-Delivery Devices are positioned for the fastest growth at a projected CAGR of 12.6%. Device Development and Manufacturing Services should remain the dominant service category with a 57.0% share, while Quality Management Services are projected to grow at a 12.8% CAGR. North America should retain market leadership with a 41.5% share, while Asia-Pacific should remain the fastest-growing region at a projected CAGR of 11.1%. Market Research Future projects the market to reach USD 249.27 Billion by 2035 at a CAGR of 9.2%.
➤➤Explore Our Latest Related Reports:
